Swedish Orphan (Sweden) Analysis

Swedish Stock Analysis Notes

About 71.0% of the company shares are owned by institutional investors. The book value of Swedish Orphan was at this time reported as 89.61. The company has Price/Earnings To Growth (PEG) ratio of 1.98. Swedish Orphan Biovitrum recorded earning per share (EPS) of 10.1. The entity had not issued any dividends in recent years. The firm had 1265:1132 split on the 3rd of May 2011. Swedish Orphan Biovitrum AB , an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haemophilia, immunology, and genetic and metabolic diseases. Swedish Orphan Biovitrum AB is headquartered in Solna, Sweden. Swedish Orphan operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. It employs 1185 people. To find out more about Swedish Orphan Biovitrum contact Guido Oelkers at 46 86 97 20 00 or learn more at https://www.sobi.com.

Swedish Orphan Biovitrum Investment Alerts

Swedish Market Capitalization

The company currently falls under 'Large-Cap' category with a current market capitalization of 73.08 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Swedish Orphan's market, we take the total number of its shares issued and multiply it by Swedish Orphan's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Swedish Profitablity

The company has Profit Margin (PM) of 0.14 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.24 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.24.

Technical Drivers

As of the 24th of April, Swedish Orphan has the Risk Adjusted Performance of (0.04), variance of 3.18, and Coefficient Of Variation of (1,340). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Swedish Orphan Biovitrum, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to interpolate thirteen technical drivers for Swedish Orphan Biovitrum, which can be compared to its competition. Please validate Swedish Orphan Biovitrum standard deviation, information ratio, maximum drawdown, as well as the relationship between the variance and treynor ratio to decide if Swedish Orphan is priced more or less accurately, providing market reflects its prevalent price of 269.0 per share.

Swedish Orphan Biovitrum Price Movement Analysis

Swedish Orphan Predictive Daily Indicators

Swedish Orphan Forecast Models

Swedish Orphan's time-series forecasting models are one of many Swedish Orphan's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Swedish Orphan's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Swedish Orphan prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Swedish shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Swedish Orphan. By using and applying Swedish Stock analysis, traders can create a robust methodology for identifying Swedish entry and exit points for their positions.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Swedish Orphan Biovitrum. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

When running Swedish Orphan's price analysis, check to measure Swedish Orphan's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Swedish Orphan is operating at the current time. Most of Swedish Orphan's value examination focuses on studying past and present price action to predict the probability of Swedish Orphan's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Swedish Orphan's price. Additionally, you may evaluate how the addition of Swedish Orphan to your portfolios can decrease your overall portfolio volatility.